GlassScriptPhysician profile
Amith George Jacob
NPI 1649534926
$3,236.17
in general payments reported to CMS, 2019-2025
10 companies · $876 in 2025
The $876 reported for 2025 was more than what 76% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.74 · 2020: $1,199 · 2022: $31.26 · 2023: $977 · 2024: $65.24 · 2025: $876.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,483 · Food and Beverage: $417 · Education: $18.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,482.68 |
| Food and Beverage | $417.20 |
| Education | $18.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,752.47 | 2023-2025 | Illumisite |
| Veran Medical Technologies, INC. | $611.55 | 2019-2020 | |
| Covidien LP | $596.88 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $78.12 | 2019 | |
| Haemonetics Corporation | $65.24 | 2024 | Teg6s Hemostasis System |
| Intuitive Surgical, INC. | $63.95 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $19.39 | 2022 | |
| Amgen INC. | $18.48 | 2025 | Tavneos |
| Pulmonx Corporation | $18.22 | 2025 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Genzyme Corporation | $11.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amith George Jacob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.